Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,443Revenue $M17.2Net Margin (%)275Z-Score9.5
Enterprise Value $M1,329EPS $2.1Operating Margin %309F-Score7
P/E(ttm))32.3Cash Flow Per Share $-1.6Pre-tax Margin (%)284Higher ROA y-yY
Price/Book22.310-y EBITDA Growth Rate %0Quick Ratio6.1Cash flow > EarningsY
Price/Sales74.75-y EBITDA Growth Rate %0Current Ratio6.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)40.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)74.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M42.9ROI % (ttm)-221.3Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACJean-Marie Eveillard 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.32)
$ 33.41673%Sold Out0
ANACJean-Marie Eveillard 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 33.41502%New holding, 92390 sh.92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Shapiro LucyDirector 2014-12-12Sell289,685$35.11-4.84view
Zane LeeSVP and Chief Medical Officer 2014-12-11Sell4,900$36.09-7.43view
Maples Kirk RSVP, Program Management 2014-12-09Sell60,000$36.52-8.52view
Plattner Jacob jSenior VP, Research 2014-12-01Sell6,875$33.340.21view
Maples Kirk RSVP, Program Management 2014-12-01Sell600$33.380.09view
Chanda SanjaySVP, Drug Development 2014-11-26Sell5,000$35-4.54view
Maples Kirk RSVP, Program Management 2014-11-03Sell600$29.114.81view
Plattner Jacob jSenior VP, Research 2014-11-03Sell6,875$29.3213.95view
Plattner Jacob jSenior VP, Research 2014-10-01Sell6,875$24.4736.53view
Maples Kirk RSVP, Program Management 2014-10-01Sell600$23.8540.08view

Press Releases about ANAC :

    Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 
    This Week's Top Insider Buys Jun 19 2013 
    comment on ANAC Mar 15 2013 
    Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
    Weekly CFO Buys Highlight: GSVC, SHO, YAVY, CMCSA, ANAC May 16 2011 

    More From Other Websites
    Growth stocks provide litmus test for stock market Nov 18 2014
    ANACOR PHARMACEUTICALS, INC. Financials Nov 14 2014
    10-Q for Anacor Pharmaceuticals, Inc. Nov 09 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 07 2014
    Anacor Pharmaceuticals to Present at the 2014 Credit Suisse Healthcare Conference Nov 07 2014
    Anacor posts 3Q loss Nov 06 2014
    Anacor posts 3Q loss Nov 06 2014
    Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results Nov 06 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results Nov 06 2014
    Q3 2014 Anacor Pharmaceuticals Inc Earnings Release - After Market Close Nov 06 2014
    Anacor Pharmaceuticals Announces Third Quarter 2014 Financial Results Conference Call and Webcast Oct 30 2014
    Anacor Pharmaceuticals Announces Third Quarter 2014 Financial Results Conference Call and Webcast Oct 30 2014
    6 stocks to watch Oct 22 2014
    Strong On High Relative Volume: Anacor Pharmaceuticals (ANAC) Oct 20 2014
    Anacor Pharmaceuticals (ANAC) Reaches New Lifetime High Today Oct 17 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Oct 16 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 10 2014
    Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $75 Million of 2.00% Convertible... Oct 09 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 08 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK